New posts

New report documents increase in HIV drug resistance to dolutegravir

Thread starter News (English) - World Health Organization
Start date Mar 6, 2024

Mar 6, 2024

Facebook X (Twitter) LinkedIn Reddit Pinterest Tumblr WhatsApp Email Share

Copy link

The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. The report shares some good news and some concerning news. It highlights high levels of HIV viral load suppression (>90%) in populations receiving dolutegravir (DTG)-containing antiretroviral therapy (ART).

Continue reading...

Click to expand...

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Already have an account? Log in here.

Facebook X (Twitter) LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

We value your privacy

We use essential cookies to make this site work, and optional cookies to enhance your experience. You can accept all cookies, reject optional cookies, or configure your preferences to choose which cookies to allow.

See further information and configure your preferences

Accept all cookies Reject optional cookies
Essential cookies

Required for core functionality, such as security, network management, and accessibility. You may not reject these cookies.

Optional cookies

Enable enhanced functionality and a personalized experience. If you reject these, certain functionalities may be unavailable.

Third-party cookies

Set by third-party service providers for purposes such as security, analytics, performance, and advertising. These cookies may also track your interaction with embedded media.

Detailed cookie usage

Privacy policy

Back

Top Bottom

New report documents increase in HIV drug resistance to dolutegravir

We value your privacy